Related Experiment Video
Updated: Jun 9, 2026
08:50
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Nephrotoxic lesions from 5-aminosalicylic Acid
British Medical Journal
|August 27, 2010
Summary
Single intravenous injection of 5-aminosalicylic acid caused kidney damage in rats. Renal papillary necrosis and cortical lesions occurred simultaneously, suggesting independent development in analgesic-associated kidney injury.
Area of Science:
- Nephrology
- Toxicology
- Pharmacology
Background:
- Analgesic abuse is linked to kidney damage, specifically renal papillary necrosis.
- The pathogenesis of analgesic-induced nephropathy, particularly cortical lesions, remains incompletely understood.
Purpose of the Study:
- To investigate the renal effects of 5-aminosalicylic acid (5-ASA) in a rat model.
- To determine the relationship between cortical and papillary renal lesions induced by 5-ASA.
Main Methods:
- Adult rats received a single intravenous injection of 5-aminosalicylic acid.
- Renal tissues were examined for histological changes, focusing on proximal convoluted tubules and renal papilla.
Main Results:
- 5-Aminosalicylic acid induced necrosis in both the proximal convoluted tubules (cortical lesions) and the renal papilla.
- These two types of lesions developed concurrently.
- Cortical lesions did not appear to be a secondary consequence of renal papillary necrosis.
Conclusions:
- 5-Aminosalicylic acid, structurally related to phenacetin and salicylates, can cause independent renal cortical and papillary damage.
- These findings suggest that analgesic-induced nephropathy may involve independent development of cortical lesions, separate from renal papillary necrosis.
- This highlights potential mechanisms underlying kidney damage from chronic analgesic misuse.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...